SE9103572D0 - Organic salts of n,n'-diacetyl cystine - Google Patents
Organic salts of n,n'-diacetyl cystineInfo
- Publication number
- SE9103572D0 SE9103572D0 SE9103572A SE9103572A SE9103572D0 SE 9103572 D0 SE9103572 D0 SE 9103572D0 SE 9103572 A SE9103572 A SE 9103572A SE 9103572 A SE9103572 A SE 9103572A SE 9103572 D0 SE9103572 D0 SE 9103572D0
- Authority
- SE
- Sweden
- Prior art keywords
- organic salts
- diacetyl cystine
- cystine
- diacetyl
- processes
- Prior art date
Links
- YTPQSLLEROSACP-YUMQZZPRSA-N (2R)-2-acetamido-3-[[(2R)-2-acetamido-2-carboxyethyl]disulfanyl]propanoic acid Chemical class CC(=O)N[C@H](C(O)=O)CSSC[C@@H](C(O)=O)NC(C)=O YTPQSLLEROSACP-YUMQZZPRSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/22—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides
- C07C319/24—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides by reactions involving the formation of sulfur-to-sulfur bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (43)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9103572A SE9103572D0 (sv) | 1991-11-29 | 1991-11-29 | Organic salts of n,n'-diacetyl cystine |
NZ245077A NZ245077A (en) | 1991-11-29 | 1992-11-10 | Isomeric forms of n,n'-diacetyl cystine salt with an organic base, preparation and pharmaceutical compositions thereof |
ZA928739A ZA928739B (en) | 1991-11-29 | 1992-11-12 | Organic salts of N,N'-diacetyl cystine. |
IL10377892A IL103778A (en) | 1991-11-29 | 1992-11-17 | Organic salts of N,N'-diacetyl cystine process for their preparation and pharmaceutical compositions containing them |
YU99092A YU48594B (sh) | 1991-11-29 | 1992-11-18 | Organske soli n-n'-diacetilcistina i postupak njihovog dobijanja |
APAP/P/1992/000448A AP350A (en) | 1991-11-29 | 1992-11-20 | Organic salts of N,N-Diacetyl cystine. |
TNTNSN92108A TNSN92108A1 (fr) | 1991-11-29 | 1992-11-23 | Sels organiques de n, n' -diacetyl cystine |
HR9103572-5A HRP921322B1 (en) | 1991-11-29 | 1992-11-23 | Organic salts of n,n'-diacetyl cystine |
MA23006A MA22716A1 (fr) | 1991-11-29 | 1992-11-24 | Sels organiques de n,n'-diacetyl cystine |
IS3949A IS1645B (is) | 1991-11-29 | 1992-11-24 | Hliðstæð aðferð við að framleiða salt af lýsini og N,N'-tvíasetýlsystíni |
AT92924975T ATE141913T1 (de) | 1991-11-29 | 1992-11-25 | Organische salze von n, n'-diacetylcystin |
HU9401473A HU215390B (hu) | 1991-11-29 | 1992-11-25 | Eljárás N,N'-diacetil-cisztin szerves bázisokkal képzett sói és az ezeket tartalmazó gyógyászati készítmények előállítására |
CA002123516A CA2123516A1 (en) | 1991-11-29 | 1992-11-25 | Organic salts of n,n'-diacetyl cystine |
PCT/SE1992/000807 WO1993011104A1 (en) | 1991-11-29 | 1992-11-25 | Organic salts of n, n'-diacetyl cystine |
EP92924975A EP0621862B1 (en) | 1991-11-29 | 1992-11-25 | Organic salts of n, n'-diacetyl cystine |
ES92924975T ES2090713T3 (es) | 1991-11-29 | 1992-11-25 | Sales organicas de n,n'-diacetil-cistina. |
SG1996004497A SG73962A1 (en) | 1991-11-29 | 1992-11-25 | Organic salts of n, n'-diacetyl cystine |
JP51003993A JP3302018B2 (ja) | 1991-11-29 | 1992-11-25 | N,n’−ジアセチルシスチンの有機塩 |
DE69213256T DE69213256T2 (de) | 1991-11-29 | 1992-11-25 | Organische salze von n, n'-diacetylcystin |
DZ920148A DZ1637A1 (fr) | 1991-11-29 | 1992-11-25 | Sels organiques de n'n'-diacétyl cystine. |
RU94027569/04A RU2135468C1 (ru) | 1991-11-29 | 1992-11-25 | Органические соли n,n'-диацетилцистина, способы их получения, фармацевтическая композиция, способ лечения |
US07/981,373 US5385904A (en) | 1991-11-29 | 1992-11-25 | Organic salts of N,N'-diacetyl cystine |
PL92303924A PL170787B1 (en) | 1991-11-29 | 1992-11-25 | Method of obtaining an organic salt and n,n'-diacetlocystine |
DK92924975.3T DK0621862T3 (da) | 1991-11-29 | 1992-11-25 | Organiske salte af N,N-diacetylcystin |
AU30996/92A AU657827B2 (en) | 1991-11-29 | 1992-11-25 | Organic salts of N, N'-diacetyl cystine |
MYPI92002155A MY110523A (en) | 1991-11-29 | 1992-11-25 | Organic salts of n, n''-dicetyl cystine |
KR1019940701815A KR100256185B1 (ko) | 1991-11-29 | 1992-11-25 | N,n'-디아세틸 시스틴의 유기염 |
CZ941297A CZ282085B6 (cs) | 1991-11-29 | 1992-11-25 | Organické soli N,N'-diacetylcystinu |
PL92314567A PL171336B1 (en) | 1991-11-29 | 1992-11-25 | Method of obtaining an organic salt and n,n'-diacetylocystine |
SK632-94A SK281697B6 (sk) | 1991-11-29 | 1992-11-25 | Soľ organickej bázy a n,n'-diacetylcystínu, spôsob jej výroby, jej použitie a farmaceutický prostriedok s jej obsahom |
MX9206851A MX9206851A (es) | 1991-11-29 | 1992-11-27 | Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene. |
CN92113666A CN1039586C (zh) | 1991-11-29 | 1992-11-28 | 制备n,n′-二乙酰胱氨酸的有机盐的方法 |
SI19929200351A SI9200351A (en) | 1991-11-29 | 1992-11-30 | Organic salts of n,n'-diacetyl cystine |
NO941968A NO301325B1 (no) | 1991-11-29 | 1994-05-26 | Organiske salter av N,N'-diacetylcystin, farmasöytisk preparat samt anvendelse av saltene |
FI942504A FI942504A (fi) | 1991-11-29 | 1994-05-27 | N,N'-diasetyylikystiinin orgaanisia suoloja |
US08/335,941 US5693858A (en) | 1991-11-29 | 1994-11-08 | Organic salts of N,N'-diacetyl cystine |
EE9400378A EE03025B1 (et) | 1991-11-29 | 1994-11-17 | Immunomoduleeriva toimega N,N'-diatsetüültsüstiini orgaanilised soolad, nende valmistamine ja kasutamine |
US08/484,143 US5824681A (en) | 1991-11-29 | 1995-06-07 | Organic salts of N,N'-diacetyl cystine |
US08/477,387 US5804582A (en) | 1991-11-29 | 1995-06-07 | Method for the treatment of diseases due to defects the immune system |
US08/476,218 US5650538A (en) | 1991-11-29 | 1995-06-07 | Organic salts of N,N'-diacetyl cystine |
GR960402920T GR3021546T3 (en) | 1991-11-29 | 1996-11-06 | Organic salts of n, n'-diacetyl cystine. |
HK62297A HK62297A (en) | 1991-11-29 | 1997-05-08 | Organic salts of N,N'-diacetyl cystine |
LVP-97-158A LV11949B (en) | 1991-11-29 | 1997-08-28 | N, N'-DIACETYL-CISTIN ORGANIC SALTS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9103572A SE9103572D0 (sv) | 1991-11-29 | 1991-11-29 | Organic salts of n,n'-diacetyl cystine |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9103572D0 true SE9103572D0 (sv) | 1991-11-29 |
Family
ID=20384494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9103572A SE9103572D0 (sv) | 1991-11-29 | 1991-11-29 | Organic salts of n,n'-diacetyl cystine |
Country Status (38)
Country | Link |
---|---|
US (5) | US5385904A (fi) |
EP (1) | EP0621862B1 (fi) |
JP (1) | JP3302018B2 (fi) |
KR (1) | KR100256185B1 (fi) |
CN (1) | CN1039586C (fi) |
AP (1) | AP350A (fi) |
AT (1) | ATE141913T1 (fi) |
AU (1) | AU657827B2 (fi) |
CA (1) | CA2123516A1 (fi) |
CZ (1) | CZ282085B6 (fi) |
DE (1) | DE69213256T2 (fi) |
DK (1) | DK0621862T3 (fi) |
DZ (1) | DZ1637A1 (fi) |
EE (1) | EE03025B1 (fi) |
ES (1) | ES2090713T3 (fi) |
FI (1) | FI942504A (fi) |
GR (1) | GR3021546T3 (fi) |
HK (1) | HK62297A (fi) |
HR (1) | HRP921322B1 (fi) |
HU (1) | HU215390B (fi) |
IL (1) | IL103778A (fi) |
IS (1) | IS1645B (fi) |
LV (1) | LV11949B (fi) |
MA (1) | MA22716A1 (fi) |
MX (1) | MX9206851A (fi) |
MY (1) | MY110523A (fi) |
NO (1) | NO301325B1 (fi) |
NZ (1) | NZ245077A (fi) |
PL (2) | PL171336B1 (fi) |
RU (1) | RU2135468C1 (fi) |
SE (1) | SE9103572D0 (fi) |
SG (1) | SG73962A1 (fi) |
SI (1) | SI9200351A (fi) |
SK (1) | SK281697B6 (fi) |
TN (1) | TNSN92108A1 (fi) |
WO (1) | WO1993011104A1 (fi) |
YU (1) | YU48594B (fi) |
ZA (1) | ZA928739B (fi) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3865463A (en) * | 1973-11-12 | 1975-02-11 | Busch & Co Inc Ag | Electrical adapter plug |
ES2092539T3 (es) * | 1991-01-10 | 1996-12-01 | Transcend Therapeutics Inc | Uso de derivados de la tiazolidina-4-carboxilato para el tratamiento de enfermedades pulmonares. |
US5747459A (en) * | 1991-02-04 | 1998-05-05 | Nestec, Ltd. | Method for insuring adequate intracellular glutathione in tissue |
US5430045A (en) * | 1992-04-23 | 1995-07-04 | Free Radical Sciences, Inc. | Method of reducing or preventing bone marrow hypoplasia |
US5447712A (en) * | 1993-12-09 | 1995-09-05 | Free Radical Sciences | Method of reducing cyclophosphamide induced hemorrhagic cystitis |
SE9500897D0 (sv) * | 1995-03-14 | 1995-03-14 | Astra Ab | The pharmacological use of certain cystine derivatives |
SE9602262D0 (sv) * | 1996-06-06 | 1996-06-06 | Astra Ab | New use of derivatives of cystine |
SE9602416D0 (sv) * | 1996-06-18 | 1996-06-18 | Astra Ab | New forms of an organic salt of N'N-diacetylcystine |
AR007398A1 (es) * | 1996-06-18 | 1999-10-27 | Astrazeneca Ab | Proceso para preparar sales inorganicas de n-n'-diacetilcistina |
US6017959A (en) * | 1996-06-18 | 2000-01-25 | Astra Aktiebolag | Forms of organic salts of N,N'-diacetylcystine |
CN1059907C (zh) * | 1997-05-23 | 2000-12-27 | 中国石油化工集团公司巴陵石化岳阳石油化工总厂 | 一种含共轭二烯轻聚合物的选择氢化方法 |
US20030203006A1 (en) * | 1997-10-29 | 2003-10-30 | Ajinomoto Co. Inc. | Immunomodulator |
US6197749B1 (en) * | 1997-10-29 | 2001-03-06 | Ajinomoto Co., Inc. | Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes |
SE9800932D0 (sv) | 1998-03-20 | 1998-03-20 | Astra Ab | New compunds |
EP1004302A3 (en) * | 1998-10-29 | 2003-06-04 | Ajinomoto Co., Inc. | Immunomodulator |
SE9900438D0 (sv) * | 1999-02-10 | 1999-02-10 | Astra Ab | The pharmacological use of certian cystine derivatives |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
SE518784C2 (sv) * | 2000-12-27 | 2002-11-19 | Nactilus Ab | "N-Acetyl-L-cystein med kompositioner för behandling av neoplasier" |
US20040156802A1 (en) * | 2001-03-13 | 2004-08-12 | Keiji Iwasaki | Cosmetics or external preparations for skin |
US6923175B2 (en) | 2002-03-20 | 2005-08-02 | Mannkind Corporation | Inhalation apparatus |
DK1786784T3 (da) | 2004-08-20 | 2011-02-14 | Mannkind Corp | Katalyse af diketopiperazinsyntese |
EP2322180B1 (en) | 2004-08-23 | 2015-05-27 | MannKind Corporation | Diketopiperazine salts for drug delivery |
US7799344B2 (en) | 2005-09-14 | 2010-09-21 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
ES2647080T3 (es) | 2006-02-22 | 2017-12-19 | Mannkind Corporation | Un método para mejorar las propiedades farmacéuticas de micropartículas que comprenden dicetopiperazina y un agente activo |
US8438729B2 (en) * | 2006-03-09 | 2013-05-14 | Canon Kabushiki Kaisha | Method of producing liquid discharge head |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
ES2929343T3 (es) | 2008-06-13 | 2022-11-28 | Mannkind Corp | Inhalador de polvo seco accionado por aspiración para la administración de fármacos |
EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
CA2754595C (en) | 2009-03-11 | 2017-06-27 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
AU2010259943C1 (en) | 2009-06-12 | 2016-03-03 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
CA2778698A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
CN102985125A (zh) | 2010-06-21 | 2013-03-20 | 曼金德公司 | 干粉药物输送系统和方法 |
BR122020008875B8 (pt) | 2011-04-01 | 2022-12-06 | Mannkind Corp | Embalagem de bolha e método de fabricação de uma embalagem de bolhas |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
AU2012328885B2 (en) | 2011-10-24 | 2017-08-31 | Mannkind Corporation | Methods and compositions for treating pain |
CN102491926B (zh) * | 2011-12-15 | 2013-09-25 | 青岛市药品检验所 | 一种硫普罗宁二硫化物的制备和纯化方法 |
EP2872205B1 (en) | 2012-07-12 | 2017-02-08 | MannKind Corporation | Dry powder drug delivery systems |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
AU2014228415B2 (en) | 2013-03-15 | 2018-08-09 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
BR112016000937A8 (pt) | 2013-07-18 | 2021-06-22 | Mannkind Corp | formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco |
CN105517607A (zh) | 2013-08-05 | 2016-04-20 | 曼金德公司 | 吹入设备和方法 |
WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
EP4142677A1 (en) * | 2020-04-28 | 2023-03-08 | Unilever IP Holdings B.V. | Personal care compositions with enhanced solubility actives |
WO2022067248A1 (en) * | 2020-09-28 | 2022-03-31 | Georgia Tech Research Corporation | Use of cystine and derivatives thereof as anti-thrombotic and thrombolytic agents |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB592631A (en) * | 1945-04-04 | 1947-09-24 | Du Pont | Cysteine and cystine |
GB954268A (en) | 1962-02-26 | 1964-04-02 | Mead Johnson & Co | Decongestant compositions comprising n-acylated sulphydryl compounds |
FR8205M (fi) * | 1968-12-20 | 1970-09-14 | ||
US3647834A (en) * | 1969-08-11 | 1972-03-07 | Mead Johnson & Co | Zinc mercaptide n-acetylcysteine carboxylate salts |
US3878305A (en) * | 1972-05-25 | 1975-04-15 | Procter & Gamble | Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids |
US3952115A (en) * | 1975-04-02 | 1976-04-20 | The Procter & Gamble Company | Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters |
US4141734A (en) * | 1975-09-11 | 1979-02-27 | Ciba-Geiby Ag | Photographic developing process |
US4093739A (en) * | 1977-06-15 | 1978-06-06 | Mead Johnson & Company | Mercaptoacylamidobenzoyl glycine and mucolytic process |
JPS6011888B2 (ja) * | 1978-10-11 | 1985-03-28 | 参天製薬株式会社 | リウマチ疾患治療薬 |
JPS56155298A (en) * | 1980-05-02 | 1981-12-01 | Tanabe Seiyaku Co | Shampoo composition |
GB2097256B (en) * | 1981-04-02 | 1985-05-30 | Morelle Jean V | Compositions containing n-butyryl alphaaminoacids |
FR2503151A1 (fr) * | 1981-04-02 | 1982-10-08 | Morelle Jean | Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux |
JPS58164566A (ja) * | 1982-03-09 | 1983-09-29 | Kenji Okawa | シスチン類の製造法 |
US4724239A (en) * | 1985-09-16 | 1988-02-09 | Morgan Lee R | Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine |
US4708965A (en) * | 1985-09-16 | 1987-11-24 | Morgan Lee R | Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives |
US4827016A (en) * | 1985-09-16 | 1989-05-02 | Morgan Lee R | Method and compounds for reducing dermal inflammations |
JPH0660157B2 (ja) * | 1985-11-20 | 1994-08-10 | 三井東圧化学株式会社 | システインからシスチンを製造する方法 |
JPS62195356A (ja) * | 1986-02-20 | 1987-08-28 | Seiwa Kasei:Kk | シスチン誘導体及びその塩 |
AT402931B (de) * | 1986-11-07 | 1997-09-25 | Pharmacia Gmbh | Verfahren zur herstellung von neuen cystinverbindungen und derenverwendung |
SE8704542D0 (sv) * | 1987-11-19 | 1987-11-19 | Draco Ab | New derivatives of cysteine |
IL98310A (en) * | 1990-06-08 | 1996-08-04 | Astra Ab | Medicinal preparations containing a history of cystine |
TW221376B (fi) * | 1990-06-28 | 1994-03-01 | Astra Ab | |
GB9111885D0 (en) * | 1991-06-03 | 1991-07-24 | Erba Carlo Spa | Nerve growth factor for use in the prevention and treatment of viral infections |
-
1991
- 1991-11-29 SE SE9103572A patent/SE9103572D0/xx unknown
-
1992
- 1992-11-10 NZ NZ245077A patent/NZ245077A/en unknown
- 1992-11-12 ZA ZA928739A patent/ZA928739B/xx unknown
- 1992-11-17 IL IL10377892A patent/IL103778A/xx not_active IP Right Cessation
- 1992-11-18 YU YU99092A patent/YU48594B/sh unknown
- 1992-11-20 AP APAP/P/1992/000448A patent/AP350A/en active
- 1992-11-23 TN TNTNSN92108A patent/TNSN92108A1/fr unknown
- 1992-11-23 HR HR9103572-5A patent/HRP921322B1/xx not_active IP Right Cessation
- 1992-11-24 IS IS3949A patent/IS1645B/is unknown
- 1992-11-24 MA MA23006A patent/MA22716A1/fr unknown
- 1992-11-25 CA CA002123516A patent/CA2123516A1/en not_active Abandoned
- 1992-11-25 DZ DZ920148A patent/DZ1637A1/fr active
- 1992-11-25 WO PCT/SE1992/000807 patent/WO1993011104A1/en active IP Right Grant
- 1992-11-25 DK DK92924975.3T patent/DK0621862T3/da active
- 1992-11-25 PL PL92314567A patent/PL171336B1/pl unknown
- 1992-11-25 DE DE69213256T patent/DE69213256T2/de not_active Expired - Fee Related
- 1992-11-25 RU RU94027569/04A patent/RU2135468C1/ru not_active IP Right Cessation
- 1992-11-25 US US07/981,373 patent/US5385904A/en not_active Expired - Lifetime
- 1992-11-25 SK SK632-94A patent/SK281697B6/sk unknown
- 1992-11-25 AT AT92924975T patent/ATE141913T1/de not_active IP Right Cessation
- 1992-11-25 AU AU30996/92A patent/AU657827B2/en not_active Ceased
- 1992-11-25 MY MYPI92002155A patent/MY110523A/en unknown
- 1992-11-25 PL PL92303924A patent/PL170787B1/pl unknown
- 1992-11-25 HU HU9401473A patent/HU215390B/hu not_active IP Right Cessation
- 1992-11-25 SG SG1996004497A patent/SG73962A1/en unknown
- 1992-11-25 EP EP92924975A patent/EP0621862B1/en not_active Expired - Lifetime
- 1992-11-25 KR KR1019940701815A patent/KR100256185B1/ko not_active IP Right Cessation
- 1992-11-25 JP JP51003993A patent/JP3302018B2/ja not_active Expired - Fee Related
- 1992-11-25 CZ CZ941297A patent/CZ282085B6/cs not_active IP Right Cessation
- 1992-11-25 ES ES92924975T patent/ES2090713T3/es not_active Expired - Lifetime
- 1992-11-27 MX MX9206851A patent/MX9206851A/es not_active IP Right Cessation
- 1992-11-28 CN CN92113666A patent/CN1039586C/zh not_active Expired - Fee Related
- 1992-11-30 SI SI19929200351A patent/SI9200351A/sl unknown
-
1994
- 1994-05-26 NO NO941968A patent/NO301325B1/no not_active IP Right Cessation
- 1994-05-27 FI FI942504A patent/FI942504A/fi unknown
- 1994-11-08 US US08/335,941 patent/US5693858A/en not_active Expired - Fee Related
- 1994-11-17 EE EE9400378A patent/EE03025B1/xx not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/477,387 patent/US5804582A/en not_active Expired - Fee Related
- 1995-06-07 US US08/484,143 patent/US5824681A/en not_active Expired - Fee Related
- 1995-06-07 US US08/476,218 patent/US5650538A/en not_active Expired - Lifetime
-
1996
- 1996-11-06 GR GR960402920T patent/GR3021546T3/el unknown
-
1997
- 1997-05-08 HK HK62297A patent/HK62297A/xx not_active IP Right Cessation
- 1997-08-28 LV LVP-97-158A patent/LV11949B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9103572D0 (sv) | Organic salts of n,n'-diacetyl cystine | |
RU94027569A (ru) | Органические соли n,n'-диацетилцистина, способ получения, фармацевтическая композиция, способы лечения | |
KR870700620A (ko) | 신규 약리학적 화합물 | |
EP0564739A3 (fi) | ||
DK0423714T3 (da) | Hårrevitaliseringsmiddel | |
NO902834D0 (no) | Regulering av mikrobiell vekst med lantibiotiske/lysosymformuleringer. | |
ES2107284T3 (es) | Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
ES2108129T3 (es) | Nuevos derivados de pirazina, su preparacion y empleo. | |
DK0623021T3 (da) | 4"-deoxyerythromycinderivater | |
ES2084015T3 (es) | Derivados de 2-aminopirimidina-4-carboxamida, su preparacion y su aplicacion en terapeutica. | |
MD1560G2 (ro) | Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri | |
ES2152379T3 (es) | Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos. | |
GR1000156B (el) | ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ. | |
DE59010025D1 (de) | Salze von N5, N10 - Methylen-5,6,7,8-tetrahydrofolsäure | |
SE8501532L (sv) | Nya lekemedelskombinationer med synergistisk verkan och forfarande for deras framstellning | |
LV10098A (lv) | Metilpiperazinazepina atvasinajumi to iegusana un lietosana | |
ES2046528T3 (es) | Derivados heterotetraciclicos de lactamas, proceso para su preparacion y composiciones farmaceuticas a base de los mismos. | |
JO1749B1 (en) | Organic salts from n, n- Thani Khalil sixty | |
IT1241927B (it) | 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono | |
ES8303297A1 (es) | Un procedimiento para la preparacion de un nuevo reptido activo. | |
FR2676448B1 (fr) | Nouveaux derives amidiques de 1-amino octahydropyrido [2,1-c] [1,4] oxazine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
ECSP951499A (es) | Compuestos ariltios |